Walleye Capital’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Walleye Capital’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,166	Closed	-$137K	–	4626
2022 Q4	$137K	Sell	11,166 -115,160	-91%	-$2.74M	﹤0.01%	2250
2022 Q3	$4.15M	Buy	126,326 +97,003	+331%	+$2.74M	0.08%	271
2022 Q2	$552K	Buy	29,323 +1,073	+4%	+$20.5K	0.02%	971
2022 Q1	$496K	Buy	+28,250	New	+$580K	0.01%	1019

Walleye Capital's CINC Position: Q1 2023 in Review

Walleye Capital sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 11,166 shares — an estimated $137K sold.

Walleye Capital first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $4.15M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Walleye Capital reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Walleye Capital sold 11,166 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $137K.
Walleye Capital first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Walleye Capital's CinCor Pharma, Inc. Common Stock position peaked at $4.15M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.